CLINICAL_TRIALS ClinicalTrials.gov record update

Reverse Triple Negative Immune Resistant Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05076682
Title field or adapter rule: {'original_value': 'Reverse Triple Negative Immune Resistant Breast Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:30.412703+00:00
Published At: 2026-10-23T00:00:00+00:00
Record Updated At: 2026-10-23
Source Retrieved At: 2026-10-31T22:18:22.973355+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Triple-negative Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-23", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT05076682"
protocolSection.identificationModule.officialTitle: "Reverse Triple Negative Immune Resistant Breast Cancer"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['Choline'], 'description': 'Choline 300mg tid or 500mg bid, p.o', 'name': 'Choline', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Choline', 'Efavirenz', 'Mecapegfilgrastim', 'Mifepristone', 'Sodium cromoglicate'], 'description': 'PD-1 antibody SHR1210 200mg q2w chemotherapy (whether and which should be given depends on the treatment regimen before enrollment)', 'name': 'anti-PD-1 antibody and chemotherapy', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Sodium cromoglicate'], 'description': 'Sodium Cromoglicate will be administered intranasally (nasal spray) (5 spray each nostril 4 times a day, 1 mg/spray)', 'name': 'Sodium Cromoglicate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Efavirenz'], 'description': 'Efavirenz 600mg qd, p.o', 'name': 'Efavirenz', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['HER2 low'], 'description': '4.8mg/kg q3w', 'name': 'SHR-A1811', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['HER2 0'], 'description': '6mg/kg q3w', 'name': 'SHR-A2102', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['HER2 0', 'HER2 low'], 'description': '1200mg q3w', 'name': 'SHR-1316', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Mecapegfilgrastim'], 'description': 'Mecapegfilgrastim, 6mg, d3, q3w, s.c.', 'name': 'Mecapegfilgrastim', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['AK131'], 'description': 'AK131, 40mg/kg i.v., q2w', 'name': 'AK131', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Theophylline'], 'description': 'Theophylline, 100mg bid, p.o.', 'name': 'Theophylline', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Mifepristone'], 'description': 'Mifepristone, 200mg, qd, d1-3, qw, p.o.', 'name': 'Mifepristone', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.